In Vivo CRO Market
In Vivo CRO Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
In Vivo CRO Market Size and Growth
The In Vivo CRO market is experiencing significant growth, driven by increased demand for preclinical research and drug development. The market size is projected to reach approximately $5 billion by 2025, influenced by advancements in technology and rising investments in biopharmaceuticals. Enhanced regulatory frameworks further support market expansion.
Companies Covered
(Covid 19 Impact Covered)
◍ Quintiles
◍ Charles River Laboratories
◍ Covance
◍ Parexel
◍ ICON Plc
The In Vivo CRO market features key players such as Quintiles, Charles River Laboratories, Covance, Parexel, and ICON Plc. These companies enhance market growth by providing essential preclinical and clinical research services, utilizing advanced technologies and expertise to streamline drug development processes. Sales revenues include:
- Charles River Laboratories: ~$3.2 billion
- ICON Plc: ~$3 billion
- Covance: ~$1.4 billion
Request Sample Report
Market Segmentation
By Application
Autoimmune
Pain Management
Oncology
CNS Conditions
Diabetes
Obesity
Others
Request Sample Report
By Product
Rodent Based
Non Rodent Based
Market Growth
Request Sample Report
$ X Billion USD
